Chips · Stock report · Aixtron (XETRA: AIXA.DE)
Aixtron — 54th of 85 in our chip section as it closes back above its 200-day average
The Closelooknet read
Aixtron (XETRA: AIXA.DE) is a middling performer in our chip section: its 11.97% gain over the past month ranks 54th of the 85 stocks we track. Our money-flow reading (a gauge of net buying pressure) is 79, still positive but slowing, after falling 47.6 points over 21 sessions. Alongside that, the stock closed Friday back above the average close of the last 200 sessions. We watch whether the close of EUR 39.67 holds above the 200-day average of EUR 37.23, or slips back under it.
Where Aixtron stands among chip stocks
Aixtron's one-month gain of 11.97% trails most of its equipment peers. Tokyo Electron (8035.T) rose less, at 7.19%. Applied Materials (AMAT) rose 23.17%, INFICON (IFCN.SW) 21.67%, ASM International (ASM.AS) 21.6% and Lam Research (LRCX) 20.52%.
On distance from the 52-week high, Aixtron is 34.34% below its 22 June close of EUR 60.42. Tokyo Electron is 23.22% below its high, Lam Research 19.81% and Applied Materials 25.31%. INFICON set a new high on 1 October.
Our money-flow and quality readings
Our money-flow reading is 79, still positive but slowing (our "warm" band). It fell 10.3 points over five sessions and 47.6 over 21.
Our composite score is 47 of 100. The balance sheet rates 92 and cash quality 70, while quality is 51, valuation and capital allocation 35 each, momentum 33 and growth 22. The Piotroski score is a check of financial health, scored 5 of 8.
Price trend
Aixtron closed at EUR 39.67 on 2 October, up 7.62% on the day and 13.99% over five sessions. It is 6.73% above its 50-day average of EUR 37.17 and 6.56% above its 200-day average of EUR 37.23. The move was 2.07 times its typical size, and its typical daily swing is about 3.68%.
The stock is up 129.24% this year and 167.14% over twelve months, but down 9.74% over three months. Its 52-week low was EUR 12.77 on 29 October 2025.
Closelooknet is a research diary. Nothing here is investment advice or a recommendation to buy or sell.